4th Quarter - Report

THORN RUN PARTNERS for HARMONY BIOSCIENCES

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to the development of therapies for rare diseases and sleep disorders. Drug pricing. Access to non-controlled medications. PDUFA Reauthorization. H.R.6000 - Cures 2.0 Act. FY2022 Budget Reconciliation/Inflation Reduction Act of 2022 (H.R.5376, P.L.117-169). H.R.5585 - Advanced Research Project Agency-Health (ARPA-H) Act. H.R.6963 - Accelerated Approval Integrity Act of 2022. H.R.2623 - Camerons Law. H.R.7667 - Food and Drug Amendments of 2022. S.4348 - FDASLA Act of 2022. H.R.6833 - Making continuing appropriations for fiscal year 2023, and for other purposes (P.L.117-180). H.R.8641 - Orphan Drug COVID-19 Mitigation Act of 2022. H.R.1730/S.670 - Speeding Therapy Access Today (STAT) Act of 2021. Issues related to raising awareness of World Narcolepsy Day.

LobbyistCovered position, as disclosed
ANDREW ROSENBERG —
BEAU SCHUYLER Legislative Director: Rep. Tanner; Legislative Director: Rep. McIntyre

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 6833 (117th), H.R. 2623 (117th), H.R. 5585 (117th), H.R. 8641 (117th), S. 670 (117th), S. 4348 (117th), H.R. 6963 (117th), H.R. 7667 (117th), H.R. 1730 (117th), H.R. 6000 (117th), H.R. 5376 (117th)

Taxation/Internal Revenue Code TAX

Issues related to the development of therapies for rare diseases and sleep disorders. Drug pricing. Access to non-controlled medications. PDUFA Reauthorization. H.R.6000 - Cures 2.0 Act. FY2022 Budget Reconciliation/Inflation Reduction Act of 2022 (H.R.5376, P.L.117-169). H.R.5585 - Advanced Research Project Agency-Health (ARPA-H) Act. H.R.6963 - Accelerated Approval Integrity Act of 2022. H.R.2623 - Camerons Law. H.R.7667 - Food and Drug Amendments of 2022. S.4348 - FDASLA Act of 2022. H.R.6833 - Making continuing appropriations for fiscal year 2023, and for other purposes (P.L.117-180). H.R.8641 - Orphan Drug COVID-19 Mitigation Act of 2022. H.R.1730/S.670 - Speeding Therapy Access Today (STAT) Act of 2021.

LobbyistCovered position, as disclosed
ANDREW ROSENBERG —
BEAU SCHUYLER —

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE

Bills named: S. 670 (117th), H.R. 7667 (117th), H.R. 6000 (117th), H.R. 2623 (117th), H.R. 5585 (117th), H.R. 1730 (117th), H.R. 6833 (117th), H.R. 8641 (117th), H.R. 5376 (117th), S. 4348 (117th), H.R. 6963 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.